ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,658Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 134

$528K Total Retail Price of All Prescriptions

Rank: 31 out of 134

428 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 428 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 428 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 7,556 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
LEVOTHYROXINE SODIUM 443 367 1 1
SIMVASTATIN 378 349 2 2
OMEPRAZOLE 291 262 3 3
AMLODIPINE BESYLATE 269 265 4 6
LOSARTAN POTASSIUM 234 206 5 11
HYDROCHLOROTHIAZIDE 213 199 6 13
POTASSIUM CHLORIDE 209 207 7 10
FUROSEMIDE 208 184 8 7
METFORMIN HCL ER 204 170 9 43
ATORVASTATIN CALCIUM 201 178 10 18
LISINOPRIL 201 183 10 4
MELOXICAM 193 167 12 35
GABAPENTIN 145 129 13 12
CITALOPRAM HBR 143 139 14 14
ALLOPURINOL 129 118 15 25
CRESTOR 128 110 16 39
HYDROCODONE-ACETAMINOPHEN 124 80 S3 17 5
ZOLPIDEM TARTRATE 113 90 18 15
DONEPEZIL HCL 112 112 19 30
METOPROLOL SUCCINATE 110 90 20 16
WARFARIN SODIUM 107 101 21 8
PAROXETINE HCL 100 69 22 46
METOPROLOL TARTRATE 92 83 23 17
ACTOS 90 85 24 81
TAMSULOSIN HCL 89 82 25 26
ALENDRONATE SODIUM 88 88 26 21
ROPINIROLE HCL 85 81 27 63
ATENOLOL 82 66 28 19
NOVOLOG FLEXPEN 79 76 29 109
PREDNISONE 76 71 30 28
TRAMADOL HCL 76 52 30 22
LANTUS 73 57 32 32
METFORMIN HCL 72 70 33 9
ZETIA 67 58 34 95
CIPROFLOXACIN HCL 66 63 35 59
OXYCODONE-ACETAMINOPHEN 65 57 S2 36 136
FLUTICASONE PROPIONATE 64 57 37 34
AZITHROMYCIN 64 61 37 78
AMITRIPTYLINE HCL 62 58 R 39 51
FENOFIBRATE 58 54 40 79
DIOVAN 54 49 41 55
RAMIPRIL 53 53 42 73
CYMBALTA 50 25 43 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.